{"id":386881,"date":"2016-04-27T00:00:00","date_gmt":"2016-04-27T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360io0017-medtech-interventional-oncology-devices-us-2016-market-analysis\/"},"modified":"2026-05-03T11:07:15","modified_gmt":"2026-05-03T11:07:15","slug":"m360io0017-medtech-interventional-oncology-devices-us-2016-market-analysis","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360io0017-medtech-interventional-oncology-devices-us-2016-market-analysis\/","title":{"rendered":"Interventional Oncology Devices | US | 2016 | Market Analysis"},"content":{"rendered":"<p>The US market for interventional oncology\u00a0devices is growing rapidly, driven by continual device improvement and the adoption of new, innovative products.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional oncology devices in the US across a 10-year period.<\/p>\n<p>\u00a0<\/p>\n<p><strong>Ablation therapy for bone and pancreatic cancer represent growth opportunities in the interventional oncology market<\/strong><\/p>\n<p>Which devices are indicated for these treatments, and how is device approval affecting adoption?<\/p>\n<p>What ablation technologies are being used off-label in these indications?<\/p>\n<p><strong>Microwave ablation devices are growing in popularity among interventional oncologists, and newer technologies, such as\u00a0<abbr title=\"Irreversible Electroporation\">IRE<\/abbr>,\u00a0are also being adopted rapidly<\/strong><\/p>\n<p>What are the advantages and disadvantages of each type of ablation device?<\/p>\n<p>How does the uptake of microwave ablation and\u00a0<abbr title=\"Irreversible Electroporation\">IRE<\/abbr>\u00a0devices affect other types of ablation devices?<\/p>\n<p>In which indications will these newer ablation devices experience the fastest adoption?<\/p>\n<p>How can companies in the fragmented microwave ablation market gain a competitive advantage?<\/p>\n<p><strong>Radioembolization beads continue to represent the largest segment of the embolization market, although microspheres and\u00a0<abbr title=\"Drug-Eluting Bead\">DEB<\/abbr>s will experience strong growth over the forecast<\/strong><\/p>\n<p>What factors (such as the recent SIRFLOX trial) will contribute to the adoption of different embolics for the treatment of both primary and secondary liver cancer?\u200b<\/p>\n","protected":false},"template":"","class_list":["post-386881","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-interventional-oncology-devices","medtech-date-857"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386881","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386881\/revisions"}],"predecessor-version":[{"id":388376,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386881\/revisions\/388376"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=386881"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}